alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 66, Number 113 (Tuesday, June 12, 2001)]
[Notices]
[Page 31680]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-14774]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the President's Cancer Panel.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended because the premature disclosure of information and the 
discussions would likely to significantly frustrate implementation of 
recommendations.

    Name of Committee: President's Cancer Panel.
    Date: June 26, 2001.
    Closed: 12:30 PM to 4:30 PM.
    Agenda: To review the 2000-2001 draft annual report and 
formulate recommendations for the future direction of the National 
Cancer Program to be submitted to the President for consideration 
prior to presentation to Congress.
    Place: National Institutes of Health, 31 Center Drive, Building 
31C, Conference Room 10, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Maureen O. Wilson, Ph.D., Executive Secretary, 
National Cancer Institute, NIH, 31 Center Drive, Building 31, Room 
4A48, Bethesda, MD 20892, (301) 496-1148.
    This notice is being published less than 15 days prior to the 
meeting due to the scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 5, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-14774 Filed 6-11-01; 8:45 am]
BILLING CODE 4140-01-M
```

[Federal Register: September 24, 2003 (Volume 68, Number 185)]
[Notices]
[Page 55289]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24se03-8]

=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

Time and Date: 11 a.m., Friday, October 3, 2003.

Place: 1155 21st St., NW., Washington, DC Room 1012.

Status: Closed.

Matters To Be Considered: Surveillance matters.

Contact Person for More Information: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 03-24315 Filed 9-22-03; 3:58 pm]
BILLING CODE 6351-01-M
```
```

[Federal Register: March 20, 1997 (Volume 62, Number 54)]
[Rules and Regulations]
[Page 13302]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20mr97-7]


[[Page 13302]]

-----------------------------------------------------------------------


COMMODITY FUTURES TRADING COMMISSION
17 CFR Part 140


Change in Titles of Personnel

AGENCY: Commodity Futures Trading Commission.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: CFTC is correcting an error in a change to titles of personnel
previously published in the Federal Register on May 13, 1996, (61 FR
21955). The original document contained an erroneous paragraph
reference.

EFFECTIVE DATE: May 13, 1996.

FOR FURTHER INFORMATION CONTACT:
Stacy Dean Yochum, Counsel to the Executive Director, Commodity Futures
Trading Commission, Three Lafayette Centre, 1155 21st St. NW.,
Washington, DC 20581, (202) 418-5157.

Correction

    In the final rule FR Doc. 96-11923, beginning on page 21954 in the
Federal Register issue of May 13, 1996, make the following correction:
    On page 21955, in the first column, in amendment 4. to
Sec. 140.735-8, the reference to ``paragraph (a)(3)'' is corrected to
read ``paragraph (b)(3).''

    Dated: March 14, 1997.
Jean A. Webb,
Secretary of the Commission.
[FR Doc. 97-6971 Filed 3-19-97; 8:45 am]
BILLING CODE 6351-01-M
```

----

**======== RETURN TO INDEX    ========**

----
EXHIBIT
31.2





SECTION
302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF DOT VN, INC.





I, Dr.
Lee Johnson, certify that:




1. I have
reviewed this quarterly report on Form 10-Q of Dot VN, Inc.;




2. Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report;




3. Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report;




4. The
registrant’s other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and have:




a)
designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;




b)
evaluated the effectiveness of the registrant’s disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the “Evaluation Date”); and




c)
presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;




5. The
registrant’s other certifying officers and I have disclosed, based on our most
recent evaluation, to the registrant’s auditors and the audit committee of
registrant’s board of directors (or persons performing equivalent
functions):




a) all
significant deficiencies in the design or operation of internal controls which
could adversely affect the registrant’s ability to record, process, summarize
and report financial data and have identified for the registrant’s auditors any
material weaknesses in internal controls; and,




b) any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant’s internal controls; and,




6. The
registrant’s other certifying officers and I have indicated in this quarterly
report whether there were significant changes in internal controls or in other
factors that could significantly affect internal controls subsequent to the date
of our most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.





Date: December 15, 2008
                      /s/ Dr. Lee JohnsonDr. Lee JohnsonPresident and Chief Financial Officer
#### UNITED STATES of America, Plaintiff-Appellee v. Bernardino LUNA-GARCIA, Defendant-Appellant.

No. 09-40152

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

May 4, 2010.

James Lee Turner, Assistant U.S. Attorney, U.S. Attorney’s Office, Houston, TX, for Plaintiff-Appellee.

Marjorie A. Meyers, Federal Public Defender, H. Michael Sokolow, Federal Public Defender’s Office, Southern District of Texas, Houston, TX, for Defendant-Appellant.

Before HIGGINBOTHAM, CLEMENT, and SOUTHWICK, Circuit Judges.

PER CURIAM: *

The Federal Public Defender appointed to represent Bernardino Luna-Garcia has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967). Luna-Garcia has not filed a response. Our independent review of the record and counsel’s brief discloses no nonfrivolous issue for appeal. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused *357from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5m Cm. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cm. R. 47.5.4.
#### Sugey GUADARRAMA MILAGROS, Petitioner, v. Eric H. HOLDER, Jr., Attorney General, Respondent.

No. 10-73677.

United States Court of Appeals, Ninth Circuit.

Submitted Dec. 19, 2011.*

Filed Jan. 4, 2012.

Nicholas W. Marchi, Carney *&*Marchi, PS, Seattle, WA, for Petitioner.

Oil, Karen Y. Stewart, Esquire, DOJ-U.S. Department of Justice, Washington, DC, Chief Counsel Ice, Office of the Chief Counsel Department of Homeland Security, San Francisco, CA, for Respondent.

Before: GOODWIN, WALLACE, and McKEOWN, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Sugey Guadarrama Milagros, a native and citizen of Mexico, petitions for review of the Board of Immigration Appeals’ (“BIA”) order denying her motion to reopen. We have jurisdiction under 8 U.S.C. § 1252. We review for abuse of discretion the denial of a motion to reopen, *Toufighi v. Mukasey,*538 F.3d 988, 992 (9th Cir.2008), and we deny the petition for review.

*608The BIA did not abuse its discretion in denying Guadarrama Milagros’ motion to reopen because it considered the evidence submitted and acted within its broad discretion in determining Guadarrama Milagros did not demonstrate prima facie eligibility for the relief sought. *See INS v. Abudu,*485 U.S. 94, 104-05, 108 S.Ct. 904, 99 L.Ed.2d 90 (1988) (the BIA may deny a motion to reopen for failure to establish a prima facie case for the underlying relief sought). We reject Guadarrama Milagros’ contention that the BIA failed to address any of her claims.

PETITION FOR REVIEW DENIED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the
undersigned officer of Strategic Storage Trust, Inc., or the Company, in connection with the Companys Quarterly Report on Form 10-Q for the period ended June 30, 2009 (the Report) hereby certifies, to his knowledge, that:



| | (i) | the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------



| | (ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | ---- | ----------------------------------------------------------------------------------------------------------------------------------------------------



| |  |        |  |                 |  |  |  |     |  |                              
| |  | ------ |  | --------------- |  |  |  | --- |  | -----------------------------
| |  | Dated: |  | August 13, 2009 |  |  |  | By: |  | /s/ H. Michael Schwartz      
| |  |        |  |                 |  |  |  |     |  | H. Michael Schwartz          
| |  |        |  |                 |  |  |  |     |  | President, CEO and Director  
| |  |        |  |                 |  |  |  |     |  | (Principal Executive Officer)
**EXHIBIT 10.17**

COMPENSATION ARRANGEMENTS WITH NAMED EXECUTIVE OFFICERS

The following are the annual salaries of our named executive officers as of March 1, 2005.

| **Name**                        |   | **Position**                                                     |   | **Salary** |    |
|---------------------------------|--------|------------------------------------------------------------------|--------|------------|---------|
|                                 |   |                                                                  |   |            |    |
| Kenneth G. Chahine, J.D., Ph.D. |   | President, Chief Executive   Officer and Director                |   | $          | 376,550 |   |
| Thomas J. Paulson               |   | Vice President,   Finance, Chief Financial Officer and Secretary |   | $          | 260,441 |   |
| Glenn Pierce, Ph.D., M.D.       |   | Vice President,   Research and Clinical Development              |   | $          | 242,179 |   |
| Dawn McGuire, M.D.              |   | Chief Medical Officer                                            |   | $          | 243,950 |   |
| Kirk Johnson, Ph.D.             |   | Vice President,   Preclinical Research                           |   | $          | 219,625 |   |

In addition to these named executive officers, we have three other executive officers who receive base salaries in amount commensurate to their position and role with the Company.

Bonuses are paid to executive officers based on subjective determinations by the Compensation Committee of amounts warranted.  There are no target bonus amounts set.
#### Robert James LEE, Plaintiff-Appellant v. Gaye KARRIKER, Defendant-Appellee.

No. 09-40968

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

June 24, 2010.

*492Robert James Lee, Tennessee Colony, TX, pro se.

Before HIGGINBOTHAM, CLEMENT, and SOUTHWICK, Circuit Judges.

PER CURIAM: *

Robert James Lee, Texas prisoner # 1094546, appeals the dismissal of his 42 U.S.C. § 1983 complaint as untimely filed and frivolous, and for failure to state a claim upon which relief may be granted.1 Lee seeks the removal of a 2003 notation in his prison records indicating that he once took part in an escape plot. He says the entry of the notation — a “security precaution designator” — violates his constitutional rights because he was not afforded a disciplinary hearing.

 By his own admission, Lee first learned of the existence of the escape notation in his record at a classification hearing on August 14, 2003. It was on this date, then, that he became aware of the facts that might ultimately support a claim.2 Yet Lee filed this federal complaint on June 14, 2008, well after the two-year statute of limitations had run.3 He puts forth no legitimate reason to excuse this tardiness so we find his lawsuit time-barred.4 And at any rate, Lee’s alleged injuries do not implicate the deprivation of a constitutional right.5 We AFFIRM the district court’s dismissal of Lee’s § 1983 action.

That said, Lee is entitled to a partial refund of the fee incurred in filing this lawsuit in the district court: according to our math, he overpaid. We VACATE the district court’s judgment denying a refund, and DIRECT that court’s clerk to refund any overpayment.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.

1

. See 28 U.S.C. § 1915A(b)(1).

2

. *See Piotrowski*v. *City of Houston,*237 F.3d 567, 576 (5th Cir.2001); *see also Moore v. McDonald,*30 F.3d 616, 621 (5th Cir.1994).

3

. *See Stanley v. Foster,*464 F.3d 565, 568 (5th Cir.2006) (applying Texas law’s two-year statute of limitations to a Texas prisoner’s § 1983 suit).

4

. *See Moreno v. Sterling Drug, Inc.,*787 S.W.2d 348, 351 (Tex.1990) (plaintiff must exercise due diligence to qualify for equitable tolling); *Rogers v. Ardella Veigel Inter Vivos Trust No. 2,*162 S.W.3d 281, 290 (Tex.App.Amarillo 2005, pet. denied) (continuing tort only exists when wrongful conduct is repeated over a period of time); *Booker v. Real Homes, Inc.,*103 S.W.3d 487, 493 (Tex.App.San Antonio 2003, pet. denied) (no fraudulent concealment when *defendant*did not have actual knowledge of the wrong) (emphasis added).

5

. *See Sandin v. Conner,*515 U.S. 472, 483-84, 115 S.Ct. 2293, 132 L.Ed.2d 418 (1995); *Malchi v. Thaler,*211 F.3d 953, 958 (5th Cir.2000); *Madison v. Parker,*104 F.3d 765, 767-68 (5th Cir.1997).
#### UNITED STATES of America, Plaintiff-Appellee, v. Anthony Dewayne GILLIS, a/k/a Toney Gillis, Defendant-Appellant.

No. 10-6632.

United States Court of Appeals, Fourth Circuit.

Submitted: Oct. 19, 2010.

Decided: Oct. 27, 2010.

*818Anthony Dewayne Gillis, Appellant Pro Se. John Staige Davis, V, Norval George Metcalf, Stephen David Schiller, Assistant United States Attorneys, Richmond, Virginia, for Appellee.

Before DUNCAN, KEENAN, and WYNN, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Anthony Dewayne Gillis seeks to appeal the district court’s order denying relief on his 28 U.S.C.A. § 2255 (West Supp. 2010) motion. The order is not appealable unless a circuit justice or judge issues a certifícate of appealability. 28 U.S.C. § 2253(c)(1) (2006). A certificate of ap-pealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2006). When the district court denies relief on the merits, a prisoner satisfies this standard by demonstrating that reasonable jurists would find that the district court’s assessment of the constitutional claims is debatable or wrong. *Slack v. McDaniel,*529 U.S. 473, 484, 120 S.Ct. 1595, 146 L.Ed.2d 542 (2000); *see Miller-El v. Cockrell,*537 U.S. 322, 336-38, 123 S.Ct. 1029, 154 L.Ed.2d 931 (2003). When the district court denies relief on procedural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is debatable, and that the motion states a debatable claim of the denial of a constitutional right. *Slack,*529 U.S. at 484-85, 120 S.Ct. 1595. We have independently reviewed the record and conclude that Gillis has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED.*
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Descanso Agency, Inc. (the "Company")
on Form 10-QSB for the period ending September 30, 2007 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Raul
Getino, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
4th day of November, 2007.


/s/ Raul Getino
---------------------------
Chief Executive Officer
#### Ernest Lee WYNN, Jr., Plaintiff-Appellant, v. Ms. BADGETT, Medical Administrator; O. Ajumobi, Dr., Institutional Physician; Ms. Burnette, Grievance Coordinator; Keith W. Davis, Warden; Dr. Ohi, Institutional Physician; D. Hodges, Superintendent; Gohar Abbasi, Dr., Institutional Physician, Defendants-Appellees.

No. 10-6857.

United States Court of Appeals, Fourth Circuit.

Submitted: Oct. 14, 2010.

Decided: Oct. 22, 2010.

Ernest Lee Wynn, Jr., Appellant Pro Se.

Before MOTZ, KING, and DAVIS, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Ernest Lee Wynn, Jr., appeals the district court’s order denying relief on his 42 U.S.C. § 1983 (2006) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *Wynn v. Badgett,*No. 1:10-cv-00490-LO-TCB (E.D. Va. June 7, 2010). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
```

[Federal Register: August 18, 2005 (Volume 70, Number 159)]
[Notices]
[Page 48547]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18au05-33]


[[Page 48547]]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

Time and Date: 1 a.m., Friday, September 30, 2005.

Place: 1155 21st St., NW., Washington, DC, 9th Floor Commission
Conference Room.

Status: Closed.

Matters to be Considered: Surveillance Matters.

Contact Person for More Information: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 05-16439 Filed 8-16-05; 10:47 am]

BILLING CODE 6351-01-M
```
CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER AND


CHIEF
      FINANCIAL OFFICER


PURSUANT
      TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002








In
      connection with the accompanying quarterly Report on Form 10-QSB of Rolling
      Technologies, Inc. for the quarter ended October 31, 2007, I certify, pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, to my knowledge, that:





|(1) | the
              quarterly Report on Form 10-QSB of Rolling Technologies, Inc. for the
              quarter ended October 31, 2007 fully complies with the requirements
              of
              Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




|(2) | the
              information contained in the quarterly Report on Form 10-QSB for the
              quarter ended October 31, 2007, fairly presents in all material respects,
              the financial condition and results of operations of Rolling Technologies,
              Inc..
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




By:
            /s/
                Tee Kai ShenName:
            Tee
                Kai ShenTitle:
            Principal
                Executive Officer,
              Principal
                Financial Officer and DirectorDate:
            December
                17, 2007